HAWTHORNE, N.Y., July 15, 2009 (GLOBE NEWSWIRE) -- Taro Pharmaceutical Industries Ltd. (“Taro,” the “Company”) (Pink Sheets:TAROF) announced that the U.S. Patent and Trademark Office has issued a patent covering its Ovide(r) (malathion) lotion, 0.5% (patent no. US 7,560,445).
